Literature DB >> 7825608

High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families.

M Zatz1, S K Marie, M R Passos-Bueno, M Vainzof, S Campiotto, A Cerqueira, C Wijmenga, G Padberg, R Frants.   

Abstract

A gene responsible for facioscapulohumeral muscular dystrophy (FSHD) has been localized at 4q35. Subsequently, it was found that probe p13E-11 detects a polymorphic EcoRI fragment, usually > 28 kb, in normal individuals, whereas in sporadic and familial FSHD cases, an EcoRI fragment, usually < 28 kb, was found. Although these findings have been amply confirmed, several aspects are as yet either controversial or unsolved. In the present investigation, 34 Brazilian FSHD families were studied at the clinical and the molecular level for the following purposes: to assess the frequency of new mutations and their effect on estimates of biological fitness, to characterize FSHD-associated EcoRI fragments detected with probe p13E-11 in familial--as compared with isolated--FSHD cases, and to assess whether anticipation occurs in multigenerational families. Results from our study suggest that new mutations are apparently frequent for FSHD and may account for at least one-third of the cases, that somatic mosaicism may not be rare, and that biological fitness appeared to be reduced in FSHD, ranging from 0.6 to 0.82 by different estimates, with no difference in sexes. Interestingly, the size of the new EcoRI fragment is apparently smaller in more severely affected isolated patients. Moreover, the age at onset of clinical signs, as well as the age at ascertainment, in patients from multigenerational families suggests that anticipation occurs for FSHD in the majority of the families.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7825608      PMCID: PMC1801310     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy.

Authors:  C Wijmenga; J E Hewitt; L A Sandkuijl; L N Clark; T J Wright; H G Dauwerse; A M Gruter; M H Hofker; P Moerer; R Williamson
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

2.  Formal genetics of muscular dystrophy.

Authors:  N E MORTON; C S CHUNG
Journal:  Am J Hum Genet       Date:  1959-12       Impact factor: 11.025

3.  Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-qter.

Authors:  C Wijmenga; L A Sandkuijl; P Moerer; N van der Boorn; S E Bodrug; P N Ray; O F Brouwer; J C Murray; G J van Ommen; G W Padberg
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

4.  No evidence of genetic heterogeneity in Brazilian facioscapulohumeral muscular dystrophy families (FSHD) with 4q markers.

Authors:  M R Passos-Bueno; C Wijmenga; R E Takata; S K Marie; M Vainzof; R C Pavanello; J E Hewitt; E Bakker; A Carvalho; J Akiyama
Journal:  Hum Mol Genet       Date:  1993-05       Impact factor: 6.150

5.  Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic cases.

Authors:  R C Griggs; R Tawil; D Storvick; J R Mendell; M R Altherr
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  Molecular analysis of British facioscapulohumeral dystrophy families for 4q DNA rearrangements.

Authors:  M Upadhyaya; P Jardine; J Maynard; J Farnham; M Sarfarazi; C Wijmenga; J E Hewitt; R Frants; P S Harper; P W Lunt
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

7.  Mapping the facioscapulohumeral muscular dystrophy gene is complicated by chromsome 4q35 recombination events.

Authors:  B Weiffenbach; J Dubois; D Storvick; R Tawil; S J Jacobsen; J Gilbert; C Wijmenga; J R Mendell; S Winokur; M R Altherr
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

8.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.

Authors:  H T Orr; M Y Chung; S Banfi; T J Kwiatkowski; A Servadio; A L Beaudet; A E McCall; L A Duvick; L P Ranum; H Y Zoghbi
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

9.  Facioscapulohumeral muscular dystrophy: aspects of genetic counselling, acceptance of preclinical diagnosis, and fitness.

Authors:  S Eggers; M R Passos-Bueno; M Zatz
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

10.  Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk.

Authors:  M R Passos-Bueno; E Bakker; A L Kneppers; R I Takata; D Rapaport; J T den Dunnen; M Zatz; G J van Ommen
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

View more
  28 in total

1.  De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.

Authors:  S M van der Maarel; G Deidda; R J Lemmers; P G van Overveld; M van der Wielen; J E Hewitt; L Sandkuijl; B Bakker; G J van Ommen; G W Padberg; R R Frants
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Petra G M Van Overveld; Lodewijk A Sandkuijl; Harry Vrieling; George W Padberg; Rune R Frants; Silvère M van der Maarel
Journal:  Am J Hum Genet       Date:  2004-05-20       Impact factor: 11.025

3.  Genetic counseling and testing for FSHD (facioscapulohumeral muscular dystrophy) in the Israeli population.

Authors:  Miri Yanoov-Sharav; Esther Leshinsky-Silver; Sarit Cohen; Chana Vinkler; Marina Michelson; Tally Lerman-Sagie; Mira Ginzberg; Menahem Sadeh; Dorit Lev
Journal:  J Genet Couns       Date:  2011-11-23       Impact factor: 2.537

Review 4.  The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy.

Authors:  Silvère M van der Maarel; Rune R Frants
Journal:  Am J Hum Genet       Date:  2005-01-24       Impact factor: 11.025

5.  Equal proportions of affected cells in muscle and blood of a mosaic carrier of facioscapulohumeral muscular dystrophy.

Authors:  Maria Manuela O Tonini; Richard J L F Lemmers; Rita C M Pavanello; Antonia M P Cerqueira; Rune R Frants; Silvere M van der Maarel; Mayana Zatz
Journal:  Hum Genet       Date:  2005-12-08       Impact factor: 4.132

6.  Role of the Chromosome Architectural Factor SMCHD1 in X-Chromosome Inactivation, Gene Regulation, and Disease in Humans.

Authors:  Chen-Yu Wang; Harrison Brand; Natalie D Shaw; Michael E Talkowski; Jeannie T Lee
Journal:  Genetics       Date:  2019-08-16       Impact factor: 4.562

7.  Isolated facial diplegia and very late-onset myopathy in two siblings: atypical presentations of facioscapulohumeral dystrophy.

Authors:  Juan J Figueroa; John E Chapin
Journal:  J Neurol       Date:  2009-10-14       Impact factor: 4.849

8.  Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression.

Authors:  R Tupler; L Barbierato; M Memmi; C A Sewry; D De Grandis; P Maraschio; L Tiepolo; A Ferlini
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

9.  [Facioscapulohumeral muscular dystrophy. Clinical picture, atypical forms, diagnostics, genetics].

Authors:  B Jordan; C Müller-Reible; S Zierz
Journal:  Nervenarzt       Date:  2011-06       Impact factor: 1.214

Review 10.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.